"Meglumine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.
| Descriptor ID |
D008536
|
| MeSH Number(s) |
D02.033.800.813.550 D09.067.342.600 D09.853.813.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Meglumine".
Below are MeSH descriptors whose meaning is more specific than "Meglumine".
This graph shows the total number of publications written about "Meglumine" by people in this website by year, and whether "Meglumine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 0 | 2 | 2 |
| 2018 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meglumine" by people in Profiles.
-
MRA of the Supraaortic Vasculature: Comparison of Gadobutrol and Gadoterate Meglumine at 1.5 T. J Magn Reson Imaging. 2022 08; 56(2):440-449.
-
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography. AJR Am J Roentgenol. 2018 11; 211(5):1063-1067.
-
Durable lesion formation while avoiding esophageal injury during ablation of atrial fibrillation: Lessons learned from late gadolinium MR imaging. J Cardiovasc Electrophysiol. 2018 03; 29(3):385-392.
-
Diffusion, Perfusion, and Histopathologic Characteristics of Desmoplastic Infantile Ganglioglioma. J Radiol Case Rep. 2016 Jul; 10(7):1-13.
-
A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
-
Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study. AJR Am J Roentgenol. 2015 Sep; 205(3):533-9.
-
Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors. Neuroradiology. 2015 Mar; 57(3):299-306.
-
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report. Br J Radiol. 2014 Oct; 87(1042):20140307.
-
Performance of spin-echo and gradient-echo T1-weighted sequences for evaluation of dural venous sinus thrombosis and stenosis. AJR Am J Roentgenol. 2013 Jul; 201(1):162-9.
-
Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Invest Radiol. 2009 May; 44(5):251-6.